Comparison of ceftazidime with cefamandole for therapy of community-acquired pneumonia.

AUTOR(ES)

Engle, J C

RESUMO

Ceftazidime and cefamandole were compared in the treatment of pneumonia. The median MIC of ceftazidime for all Streptococcus pneumoniae (n = 17) and Haemophilus influenzae (n = 10) isolates was 0.125 microgram/ml. All other isolates were inhibited by less than 0.5 microgram of ceftazidime per ml, with the exception of a group B streptococcus (MIC = 4 micrograms/ml). Satisfactory clinical responses were observed in 91% (20 of 22) of cefamandole-treated patients and 85% (17 of 20) of ceftazidime-treated patients.

Documentos Relacionados

• Ampicillin versus cefamandole as initial therapy for community-acquired pneumonia.
• Comparative trial of cefonicid and cefamandole in the therapy of community-acquired pneumonia.
• Community-acquired Chlamydia pneumoniae pneumonia.
• Comparison of cefdinir and cefaclor in treatment of community-acquired pneumonia.
• Diagnosis and antibiotic treatment of community-acquired pneumonia.